And a key role for receptor-interacting serine/threonine-protein kinase 3 (RIPK3) in preventing hematopoietic malignancies is through specific mediation of necroptosis in myeloid leukaemia cells (Hockendorf et al., 2016). This evidence concerns the gene RIPK3 and myeloid leukemia.